{"id":25168,"date":"2024-03-08T09:30:00","date_gmt":"2024-03-08T08:30:00","guid":{"rendered":"https:\/\/idibell.cat\/?p=25168"},"modified":"2024-03-07T11:12:35","modified_gmt":"2024-03-07T10:12:35","slug":"8m-cada-8-minuts-mor-una-dona-per-malaltia-cardiovascular","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2024\/03\/8m-cada-8-minuts-mor-una-dona-per-malaltia-cardiovascular\/","title":{"rendered":"8M: Cada 8 minuts mor una dona per malaltia cardiovascular"},"content":{"rendered":"

Aquest 8M, l\u2019IDIBELL vol posar el focus en les malalties cardiovasculars en les dones. Les malalties cardiovasculars s\u00f3n considerades la primera causa de mort en dones a Espanya, per davant del c\u00e0ncer de mama. De fet, s\u2019estima que a l\u2019estat cada 8 minuts mor una dona per malaltia cardiovascular. Tot i aix\u00ed, aquest tipus d\u2019afectacions continuen estant infradiagnosticades per un c\u00famul de factors que evidencien l\u2019exist\u00e8ncia d\u2019un biaix de g\u00e8nere en medicina que encara ha de superar-se.<\/p>\n

La inespecificitat en el diagn\u00f2stic es mant\u00e9 com un dels esculls m\u00e9s significatius, i l\u2019infart de miocardi n\u2019\u00e9s un exemple paradigm\u00e0tic. La manifestaci\u00f3 cl\u00ednica dels infarts en dones \u00e9s lleugerament diferent a la d\u2019ells i presenten s\u00edmptomes addicionals, com ara n\u00e0usees, mal de cap i sensaci\u00f3 de mareig, que s\u00f3n m\u00e9s intensos que en homes. La desconeixen\u00e7a d\u2019aquestes difer\u00e8ncies i l\u2019exist\u00e8ncia de s\u00edmptomes acompanyants compliquen i endarrereixen el diagn\u00f2stic, ja que no s\u2019identifica el problema i es confon sovint amb quadres d\u2019ansietat o estr\u00e8s. A part, s\u2019ha vist que les dones tendeixen a minimitzar els s\u00edmptomes i triguen m\u00e9s a anar a l\u2019hospital, arribant-hi quan ja estan en insufici\u00e8ncia card\u00edaca. En conjunt, tot aix\u00f2 fa que rebin el tractament molt m\u00e9s tard del normal.<\/p>\n

Part del desconeixement de la patologia cardiovascular femenina es deu a una manca de recerca d\u2019aquestes malalties en dones. Als anys 90, es va veure que existia un biaix inconscient en els programes d\u2019investigaci\u00f3 i els assajos cl\u00ednics, que tendien a reclutar cohorts conformades \u00edntegrament per homes i assumien que els resultats es podrien extrapolar a les dones. Aquest biaix s\u2019ha anat corregint en els \u00faltims anys, per\u00f2 en el camp de la prevenci\u00f3 encara falta posar l\u2019accent en l\u2019estudi de factors de risc particularment importants per les dones (com ho serien la diabetis gestacional, els parts prematurs o la menopausa).<\/p>\n

Per tot aix\u00f2, \u00e9s necessari potenciar la recerca biom\u00e8dica de patologia cardiovascular en dones, entrenar els professionals en la identificaci\u00f3 i diferenciaci\u00f3 dels s\u00edmptomes en unes i altres, i donar m\u00e9s import\u00e0ncia a s\u00edmptomes de malalties cardiovasculars que normalment es relacionen amb l\u2019estr\u00e8s o l\u2019ansietat. En aquest sentit, no nom\u00e9s cal incidir en els professionals, sin\u00f3 que tamb\u00e9 \u00e9s clau promocionar l\u2019autocura i el reconeixement d\u2019aquests s\u00edmptomes entre les dones per afavorir que acudeixin a l\u2019hospital abans i es pugui prevenir el seu empitjorament.<\/p>\n

Precisament, aquest focus en la prevenci\u00f3 \u00e9s el que segueix el grup de Recerca en Malalties Cardiovasculars (BIO-HEART)<\/a> de l\u2019IDIBELL i l\u2019Hospital Universitari de Bellvitge que, entre altres, treballa en la implementaci\u00f3 d\u2019eines d’intel\u00b7lig\u00e8ncia artificial per desenvolupar estrat\u00e8gies preventives integradores per a malalties cardiovasculars. En l\u2019\u00e0mbit de la correcci\u00f3 del biaix de g\u00e8nere, les investigadores de l\u2019IDIBELL i l\u2019HUB Cristina Enjuanes i Oona Mero\u00f1o lideren un projecte, finan\u00e7at per La Marat\u00f3 de 3Cat, que aborda les difer\u00e8ncies de g\u00e8nere en l\u2019acc\u00e9s de les dones als programes de rehabilitaci\u00f3 despr\u00e9s d\u2019una s\u00edndrome coron\u00e0ria aguda. Aquest estudi ajudar\u00e0 a dissenyar estrat\u00e8gies personalitzades per tal que les dones tinguin un acc\u00e9s equitatiu a intervencions terap\u00e8utiques de les que ara queden, sovint, excloses.<\/p>\n

 <\/p>\n

 <\/p>\n

 <\/p>\n

L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n

L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Aquest 8M, l’IDIBELL vol posar el focus en les malalties cardiovasculars en les dones<\/p>\n","protected":false},"author":8,"featured_media":25181,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[359,334,466],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-15 21:58:00","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25168"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=25168"}],"version-history":[{"count":2,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25168\/revisions"}],"predecessor-version":[{"id":25180,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/25168\/revisions\/25180"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/25181"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=25168"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=25168"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=25168"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}